PAR 0.00% 22.5¢ paradigm biopharmaceuticals limited..

True - but the guidance is for acute not chronic pain and also,...

  1. 2,150 Posts.
    lightbulb Created with Sketch. 581
    True - but the guidance is for acute not chronic pain and also, its up to Paradigm a bit - why the hell haven't they applied for a FastTrack designation is beyond me. Yes, it comes into play at NDA time, but would do a lot for investor confidence.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $78.73M
Open High Low Value Volume
23.0¢ 23.0¢ 21.5¢ $78.13K 350.8K

Buyers (Bids)

No. Vol. Price($)
2 64880 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 43479 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.